SGN-CD352A: A novel humanized anti-CD352 antibody -drug conjugate for the treatment of multiple myeloma

被引：10
|
作者：
Lewis, Tim
Olson, Devra J.
Gordon, Kristine A.
Sandal, Sharsti L.
Miyamoto, Jamie
VVestendorf, Lori
Linares, Germein
Leiske, Chris
Kostner, Heather
Stone, Ivan
Anderson, Martha
Nesterova, Albina
Jonas, Mechthild
Law, Che-Leung
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1195
引用
收藏
页数：3
相关论文
共 50 条
  • [1] SGN-CD48A: a Novel Humanized Anti-CD48 Antibody-Drug Conjugate for the Treatment of Multiple Myeloma
    Lewis, Tim S.
    Olson, Devra
    Gordon, Kristine
    Sandall, Sharsti
    Quick, Marsha
    Finn, Margo
    Westendorf, Lori
    Linares, Germein
    Leiske, Chris
    Nesterova, Albina
    Huang, Lanshan
    Goswami, Maitrayee
    Wang, Sa
    Law, Che-Leung
    BLOOD, 2016, 128 (22)
  • [2] SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors
    Sandall, Sharsti L.
    Mason, Marsha
    Olson, Devra
    Mazahreh, Rebecca
    Sahetya, Disha
    Westendorf, Lori
    Leiske, Chris
    Schimpf, Brian
    Nguyen, Liem
    Katepalli, Madhu
    Trueblood, Esther
    Hale, Christopher
    Nesterova, Albina
    Wall, Jason
    Lewis, Timothy S.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] SGN-CD19A: A novel Anti-CD19 antibody drug conjugate
    Albertson, Tina M.
    Sandalic, Lali
    Zhao, Baiteng
    Kostic, Ana
    Law, Che-Leung
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Phase I trial of a humanized anti-CD40 monoclonal antibody (SGN-40) in the treatment of multiple myeloma.
    Hussein, MA
    Berenson, JR
    Niesvizky, R
    Munshi, NC
    Anderson, KC
    Ryan, KL
    Baumgartner, KT
    Miller, DM
    Drachman, JG
    McDonald, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 580S - 580S
  • [5] A phase I humanized Anti-CD40 monoclonal antibody (SGN-40) in patients with multiple myeloma.
    Hussein, MA
    Berenson, JR
    Niesvizky, R
    Munshi, NC
    Harrop, KL
    McDonald, M
    Drachman, JG
    BLOOD, 2005, 106 (11) : 723A - 723A
  • [6] The anti-CD30 antibody-drug conjugate SGN-35 is a potent therapy for the treatment of CD30+malignancies
    Barton, J
    Hamblett, K
    Cerveny, C
    Andreyka, J
    Kissler, K
    Stone, I
    Sun, M
    Senter, P
    Wahl, A
    Francisco, J
    Ihle, N
    ANNALS OF ONCOLOGY, 2005, 16 : 134 - 134
  • [7] Novel anti-CD84 humanized monoclonal antibody enhances anti-tumor immunity in multiple myeloma
    Gunes, Metin
    Lewinsky, Hadas
    Dang, Jessica
    Ma, Ning
    Vaidehi, Nagarajan
    Janakiram, Murali
    Feng, Mingye
    Shachar, Idit
    Rosen, Steven
    Gunes, E. Gulsen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S91 - S91
  • [8] SGN-35C: A Novel CD30-Directed Antibody-Drug Conjugate for the Treatment of Lymphomas
    Hamblett, Kevin J.
    Cochran, Julia
    Snead, Katie
    Jin, Steven
    Yumul, Roma
    Simmons, Jessica
    Stone, Ivan
    Lyski, Ryan
    Schrum, Jason P.
    Lim, Andrea R.
    Clarke, Astrid
    BLOOD, 2023, 142
  • [9] A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
    Hussein, Mohamad
    Berenson, James R.
    Niesvizky, Ruben
    Munshi, Nikhil
    Matous, Jeffrey
    Sobecks, Ronald
    Harrop, Kate
    Drachman, Jonathan G.
    Whiting, Nancy
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 845 - 848
  • [10] TARGETING CD74 IN MULTIPLE MYELOMA WITH A NOVEL ANTIBODY DRUG CONJUGATE, STRO-001
    Embry, M.
    Li, X.
    DeAlmeida, V.
    Abrahams, C.
    Yu, A.
    Krimm, S.
    Krueger, S.
    Matheny, S.
    Kline, T.
    Yam, A.
    Stafford, R.
    Hallam, T.
    Lupher, M.
    Molina, A.
    HAEMATOLOGICA, 2017, 102 : 106 - 106
12345